Well Dimerix has offically been re-rated. After a decent rise we had a few weeks of sideways action with good volume to absorb any seller making a good quick profit. Fair enough. Now it looks like we're positioned for the next price increase ahead of results.
I suspect and hope that in the next couple of weeks, the company will make an announcement to say that the last FSGS patient has been dosed. They should use that opportunity to give a clearer indication on when actual results will be announced.
Chartwatch - DXB, page-36
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.030(8.00%) |
Mkt cap ! $225.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.5¢ | 37.0¢ | $637.2K | 1.624M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16500 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 169113 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |